NCT06426420

Brief Summary

The goal of this study is to explore the use of mid-infrared spectroscopy (ATR-FTIR) as a detection tool for endometriosis in urine.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
600

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Sep 2022

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 15, 2022

Completed
1.7 years until next milestone

First Submitted

Initial submission to the registry

May 14, 2024

Completed
9 days until next milestone

First Posted

Study publicly available on registry

May 23, 2024

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 29, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 29, 2026

Completed
Last Updated

May 29, 2024

Status Verified

May 1, 2024

Enrollment Period

3.6 years

First QC Date

May 14, 2024

Last Update Submit

May 26, 2024

Conditions

Keywords

EndometriosisDiagnosisSpectroscopyFTIRUrineDetectionInfrared

Outcome Measures

Primary Outcomes (1)

  • Spectroscopy Reliability (diagnostic metrics)

    The primary outcome is the evaluation of specificity, sensitivity and accuracy of the diagnostic. Acceptable diagnostic metrics must be comparable to MRI, which will demonstrate if spectroscopy can discriminate between negative and positive endometriosis patients.

    1 year

Study Arms (1)

Pelvic Pain

EXPERIMENTAL

Patients referred to the gynecology outpatient clinic, with complain of pelvic pain. Positives and negatives for endometriosis will be outlined by an expert gynecologist according to the following criteria: * Pelvic MRI (Magnetic Resonance Imaging) report; * Gynecologic exam; * Clinical symptoms and history; The intervention is the use of the ATR-FTIR Spectrometer in patient's urine samples to develop and validate a tool for detecting endometriosis.

Diagnostic Test: FTIR spectroscopy analysis

Interventions

ATR-FTIR Spectroscopy analysis combined with machine learning algorithms.

Pelvic Pain

Eligibility Criteria

Age18 Years - 55 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsBiological woman self-identified as woman
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Female
  • Pelvic pain complain

You may not qualify if:

  • Age under 18 or above 55
  • Lack of informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital Cassiano Antonio Moraes at Federal Univeristy Of Espírito Santo

Vitória, Espírito Santo, 29041-295, Brazil

RECRUITING

MeSH Terms

Conditions

EndometriosisDisease

Condition Hierarchy (Ancestors)

Genital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Valerio G Barauna, PhD

    Universidade Federal do Espírito Santo

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Valerio G Barauna, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

May 14, 2024

First Posted

May 23, 2024

Study Start

September 15, 2022

Primary Completion

April 29, 2026

Study Completion

April 29, 2026

Last Updated

May 29, 2024

Record last verified: 2024-05

Data Sharing

IPD Sharing
Will not share

Locations